Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose remimazolam plus sufentanil for sedation during ultrasound-guided nerve block
ChiCTR2000035555Phase 4Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and sufentanil (3 arms), sponsored by Anhui Provincial Tumor Hospital. Primary endpoints: Hemodynamic index, SpO2 and 2 more. Started Aug 2020; status: recruiting.
02
Drugs
remimazolamsufentanil
Beyond the preview
Go deeper on ChiCTR2000035555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035555.